Taira C A
Cátedra de Farmacología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
Pharmacol Res. 1998 Apr;37(4):255-63. doi: 10.1006/phrs.1997.0295.
A study was carried out relating to the anticholinergic action of clonidine on the cardiovascular responses to i.c.v. injection of neostigmine, a quaternary anticholinesterase, in conscious sham-operated animals and rats with sinoaortic denervation, 7 days after the corresponding operation. Neostigmine (0.1-1 micrograms i.c.v.) induced a dose-dependent pressor and bradycardic responses in sham-operated rats but induced only an increase in blood pressure in sinoaortic-denervated animals. However, the pressor response in sinoaortic-denervated rats was significantly greater than in sham-operated animals. Clonidine (10 micrograms kg-1 i.v.) induced a fall in mean arterial pressure in sinoaortic-denervated rats but not in sham-operated animals. Moreover, sinoaortic denervation reduced the bradycardic action of this antihypertensive drug. The anticholinesterase activity of clonidine (10 micrograms kg-1 i.v.), given 30 min previously, prevented the bradycardic action of neostigmine (0.1-1 micrograms i.c.v.) but failed to modify the pressor effect in sham-operated rats. This alpha2-adrenergic agent reduced the pressor response to i.c.v. administration of neostigmine in sinoaortic-denervated rats. Alternatively, the i.c.v. administration of clonidine (3 micrograms i.c.v.), given either 15 or 30 min before neostigmine, only prevented the bradycardic effect of the anticholinesterase (0.3 micrograms i.c.v.) in sham-operated rats but not the pressor action of this drug. In sinoaortic denervated rats, 3 micrograms of clonidine i.c.v. reduced an increase in blood pressure by i.c.v. injection of the anticholinesterase. The results suggest different central cholinergic mechanisms and different cholinergic-adrenergic interactions on the cardiovascular responses elicited by centrally injected neostigmine in sinoaortic denervated rats.
在假手术动物和经窦主动脉去神经支配的大鼠相应手术后7天,进行了一项关于可乐定对心血管系统对脑室内注射新斯的明(一种季铵类抗胆碱酯酶)反应的抗胆碱能作用的研究。新斯的明(0.1 - 1微克,脑室内注射)在假手术大鼠中诱导出剂量依赖性的升压和心动过缓反应,但在经窦主动脉去神经支配的动物中仅诱导血压升高。然而,经窦主动脉去神经支配大鼠的升压反应明显大于假手术动物。可乐定(10微克/千克,静脉注射)使经窦主动脉去神经支配大鼠的平均动脉压下降,但对假手术动物无此作用。此外,窦主动脉去神经支配减弱了这种抗高血压药物的心动过缓作用。预先30分钟给予可乐定(10微克/千克,静脉注射),其抗胆碱酯酶活性可预防新斯的明(0.1 - 1微克,脑室内注射)的心动过缓作用,但未能改变假手术大鼠的升压作用。这种α2 - 肾上腺素能药物减弱了经窦主动脉去神经支配大鼠对脑室内注射新斯的明的升压反应。或者,在新斯的明前15或30分钟脑室内给予可乐定(3微克,脑室内注射),仅能预防假手术大鼠中抗胆碱酯酶(0.3微克,脑室内注射)的心动过缓作用,而不能预防其升压作用。在经窦主动脉去神经支配的大鼠中,3微克脑室内注射的可乐定可减轻脑室内注射抗胆碱酯酶引起的血压升高。结果表明,在经窦主动脉去神经支配的大鼠中,中枢注射新斯的明引发的心血管反应存在不同的中枢胆碱能机制和不同的胆碱能 - 肾上腺素能相互作用。